Samsara BioCapital’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-262,827
Closed -$300K 56
2023
Q1
$300K Sell
262,827
-134,008
-34% -$195K 0.06% 46
2022
Q4
$318K Hold
396,835
0.07% 48
2022
Q3
$623K Hold
396,835
0.15% 46
2022
Q2
$710K Hold
396,835
0.19% 47
2022
Q1
$1.26M Hold
396,835
0.32% 43
2021
Q4
$1.2M Hold
396,835
0.24% 41
2021
Q3
$2.47M Hold
396,835
0.41% 36
2021
Q2
$3.38M Hold
396,835
0.44% 35
2021
Q1
$6.08M Sell
396,835
-78,108
-16% -$1.27M 1.22% 21
2020
Q4
$7.67K Sell
474,943
-142,617
-23% -$2.14M 0.77% 15
2020
Q3
$8.63M Buy
617,560
+107,264
+21% +$1.6M 2.41% 12
2020
Q2
$10.9M Sell
510,296
-86,542
-15% -$1.53M 3.49% 10
2020
Q1
$9.88M Buy
596,838
+5,470
+0.9% +$99.2K 5.68% 7
2019
Q4
$9.15M Hold
591,368
4.38% 8
2019
Q3
$7.24M Hold
591,368
4.93% 8
2019
Q2
$11.1M Buy
+591,368
New +$10.7M 7.36% 7

Other funds holding BCEL